Pharmacia PR vet Faraji named VP at Schering-Plou

KENILWORTH, NJ: Schering-Plough has named Mary-Frances Faraji its new VP of global product communications and advocacy development. She previously led PR efforts for Pfizer on a temporary basis following the company's recent merger with Pharmacia.

KENILWORTH, NJ: Schering-Plough has named Mary-Frances Faraji its new VP of global product communications and advocacy development. She previously led PR efforts for Pfizer on a temporary basis following the company's recent merger with Pharmacia.

The appointment makes Faraji the fourth senior addition to Schering's communications department to come from Pharmacia, where she served as senior director of PR and advocacy development prior to taking on the five-month interim post at Pfizer. She joins Ellen Geisel, head of Schering's allergy franchise; Carrie Cox, EVP and president of global pharmaceuticals; and recently named group VP of global communications Jeff Winton. All three formerly worked in communications at Pharmacia.

Faraji will report directly to Winton in the new post, where she will have responsibility for product communications and advocacy development on a worldwide basis. The newly created role was developed as part of Schering's effort to establish what Faraji called "a dedicated, non-advertising communications product group."

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.